Perioperative complications of laparoscopic sacrohysteropexy versus sacrocolpopexy with subtotal hysterectomy for pelvic organ prolapse.

IF 2.3 3区医学 Q3 UROLOGY & NEPHROLOGY

BMC Urology Pub Date : 2026-06-05 DOI:10.1186/s12894-026-02211-4

Shada Alanazi, Najd Alshammari, Arwa Jrais, Nawal Alharbi, Mai Alsaadoon, Yaseer Alanazi, Jawaher Alsahabi

{"title":"Perioperative complications of laparoscopic sacrohysteropexy versus sacrocolpopexy with subtotal hysterectomy for pelvic organ prolapse.","authors":"Shada Alanazi, Najd Alshammari, Arwa Jrais, Nawal Alharbi, Mai Alsaadoon, Yaseer Alanazi, Jawaher Alsahabi","doi":"10.1186/s12894-026-02211-4","DOIUrl":null,"url":null,"abstract":"Background: Pelvic organ prolapse (POP) affects 23.4% of women in Saudi Arabia. Laparoscopic sacrocolpopexy is the established surgical gold standard; however, whether concomitant hysterectomy confers additional perioperative risk remains debated.Methods: This retrospective cohort study included 179 women who underwent laparoscopic sacrocolpopexy with subtotal hysterectomy (n = 119) or laparoscopic sacrohysteropexy (n = 60) at two tertiary referral centers in Riyadh, Saudi Arabia, between 2009 and 2024. Intraoperative and postoperative complications, perioperative hemoglobin change, and hospital stay duration were compared between groups.Results: The sacrocolpopexy group was significantly older (P = 0.004). Organ injury occurred in 0.6% of cases overall. Blood transfusion was required exclusively in the sacrohysteropexy group (3.3% vs. 0.0%, P = 0.045). Both groups demonstrated a statistically significant postoperative hemoglobin decline - sacrocolpopexy: 124.52 ± 15.07 to 110.60 ± 13.77 g/L; sacrohysteropexy: 125.27 ± 13.20 to 110.29 ± 12.18 g/L (P < 0.001) - with no significant between-group difference (P = 0.747) and neither decline reaching clinical significance. Sacrohysteropexy was associated with shorter hospitalization (44.6% vs. 24.6% discharged within two postoperative days, P = 0.012). Reoperation rates and symptom resolution were comparable between groups.Conclusions: No significant between-group differences in perioperative morbidity were detected. Sacrohysteropexy was associated with shorter hospital stay; however, the clinical relevance of the higher transfusion rate is uncertain, given the small event count. Given baseline group non-comparability and the retrospective design, these results should be regarded as exploratory. The surgical approach should be individualized based on patient characteristics and the surgeon's expertise. Prospective randomized trials are warranted.","PeriodicalId":9285,"journal":{"name":"BMC Urology","volume":" ","pages":""},"PeriodicalIF":2.3000,"publicationDate":"2026-06-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13465000/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMC Urology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s12894-026-02211-4","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Background: Pelvic organ prolapse (POP) affects 23.4% of women in Saudi Arabia. Laparoscopic sacrocolpopexy is the established surgical gold standard; however, whether concomitant hysterectomy confers additional perioperative risk remains debated.

Methods: This retrospective cohort study included 179 women who underwent laparoscopic sacrocolpopexy with subtotal hysterectomy (n = 119) or laparoscopic sacrohysteropexy (n = 60) at two tertiary referral centers in Riyadh, Saudi Arabia, between 2009 and 2024. Intraoperative and postoperative complications, perioperative hemoglobin change, and hospital stay duration were compared between groups.

Results: The sacrocolpopexy group was significantly older (P = 0.004). Organ injury occurred in 0.6% of cases overall. Blood transfusion was required exclusively in the sacrohysteropexy group (3.3% vs. 0.0%, P = 0.045). Both groups demonstrated a statistically significant postoperative hemoglobin decline - sacrocolpopexy: 124.52 ± 15.07 to 110.60 ± 13.77 g/L; sacrohysteropexy: 125.27 ± 13.20 to 110.29 ± 12.18 g/L (P < 0.001) - with no significant between-group difference (P = 0.747) and neither decline reaching clinical significance. Sacrohysteropexy was associated with shorter hospitalization (44.6% vs. 24.6% discharged within two postoperative days, P = 0.012). Reoperation rates and symptom resolution were comparable between groups.

Conclusions: No significant between-group differences in perioperative morbidity were detected. Sacrohysteropexy was associated with shorter hospital stay; however, the clinical relevance of the higher transfusion rate is uncertain, given the small event count. Given baseline group non-comparability and the retrospective design, these results should be regarded as exploratory. The surgical approach should be individualized based on patient characteristics and the surgeon's expertise. Prospective randomized trials are warranted.

查看原文本刊更多论文

腹腔镜骶髂子宫固定术与骶髂子宫固定术联合子宫次全切除术治疗盆腔器官脱垂的围手术期并发症。

背景：盆腔器官脱垂（POP）影响23.4%的沙特妇女。腹腔镜骶骶固定术是公认的手术金标准；然而，是否合并子宫切除术会带来额外的围手术期风险仍存在争议。方法：本回顾性队列研究包括2009年至2024年间在沙特阿拉伯利雅得的两家三级转诊中心接受腹腔镜骶阴道固定术合并子宫次全切除术（119例）或腹腔镜骶子宫固定术（60例）的179名妇女。比较两组患者术中、术后并发症、围手术期血红蛋白变化及住院时间。结果：骶colpop固定术组患者明显老年化（P = 0.004）。器官损伤发生率为0.6%。骶子宫切除术组只需要输血（3.3% vs. 0.0%, P = 0.045）。两组患者术后血红蛋白水平均有统计学意义的下降——骶colpopexy: 124.52±15.07 ~ 110.60±13.77 g/L；骶子宫切除术：125.27±13.20 ~ 110.29±12.18 g/L (P)结论：两组围手术期发病率无显著差异。骶子宫切除术与较短住院时间相关；然而，较高的输血率的临床相关性是不确定的，考虑到小事件计数。考虑到基线组的不可比较性和回顾性设计，这些结果应被视为探索性的。手术方法应根据患者特点和外科医生的专业知识进行个体化治疗。前瞻性随机试验是必要的。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

BMC Urology UROLOGY & NEPHROLOGY-

CiteScore

3.20

自引率

0.00%

发文量

177

审稿时长

>12 weeks

期刊介绍： BMC Urology is an open access journal publishing original peer-reviewed research articles in all aspects of the prevention, diagnosis and management of urological disorders, as well as related molecular genetics, pathophysiology, and epidemiology. The journal considers manuscripts in the following broad subject-specific sections of urology: Endourology and technology Epidemiology and health outcomes Pediatric urology Pre-clinical and basic research Reconstructive urology Sexual function and fertility Urological imaging Urological oncology Voiding dysfunction Case reports.